How to detect previous exposure to Covid-19 through antibody testing, to better identify and understand community transmission

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $306,158.78
  • Funder

    MBIE New Zealand
  • Principal Investigator

    Dr. Nikki Moreland
  • Research Location

    New Zealand
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

This project has focused on establishing a way to provide evidence that an individual has been previously exposed to Covid-19 by detecting the presence of virus antibodies in blood. Accurate antibody-based tests (also known as serological tests) will underpin multiple strands of the pandemic response including clinical diagnostics and efforts to understand transmission and the immune response to SARS-CoV-2. The assay platform for antibody testing will be established in the Infection and Immunity laboratories at the University of Auckland as part of a collaborative effort involving scientists and clinicians across the country. The Covid antigens are being produced by groups at Callaghan Innovation and in the School of Biological Sciences at the University of Auckland.